2m 2m 2m 2m 2m 2m 2m
JAGUAR HEALTH (JAGX)
NASDAQ
$2.96-$0.27 (-8.23%)
Price as of Jun 03, 2026 7:11 PM EDT- $2.3MMarket Cap
- -97.57%1-Year Change
- BiotechnologyIndustry
JAGUAR HEALTH (JAGX)
$2.96-$0.27 (-8.23%)
JAGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.22 | ||
Change | -$0.05 (-1.53%) | ||
Open | $3.23 | ||
High | $3.30 | ||
Low | $3.15 | ||
Previous Close | $3.27 | ||
Volume | 21,112 | ||
30-Day Average Volume | 156,229 | ||
1-Week Change | 3.54% | ||
1-Month Change | -51.87% | ||
1-Year Change | -97.57% | ||
3-Year Change | -99.99% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 657,356 | ||
Total Assets | $38.3M | ||
Market Cap | $2.3M | ||
Enterprise Value | $43.9M | ||
Period: QTR TTM FY | |||
Revenue | $3.2M | ||
Net Income | -$23.2M | ||
Free Cash Flow | -$5.5M | ||
EBIT | -$23.2M | ||
EBITDA | -$22.7M | ||
Net Working Capital | -$20.3M | ||
EPS | -$132.56 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 14 | ||
P/B | -0 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 04/30/2026 | ||
Earnings & Revenue